| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 2490-2494, Copyright © 1995 by Endocrine Society
ARTICLES |
AC Latronico, J Anasti, IJ Arnhold, BB Mendonca, S Domenice, MC Albano, K Zachman, BL Wajchenberg and C Tsigos
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892, USA.
Familial male-limited precocious puberty (FMPP) is an autosomal dominant gonadotropin-independent disorder. Affected males generally develop signs of precocious puberty in early childhood. They typically show Leydig cell hyperplasia and increased testosterone production typical for their age, whereas circulating LH concentrations remain prepubertal. Several dominant point mutations of the LH receptor gene were identified in pedigrees with familial male-limited precocious puberty and were shown to cosegregate with the disease. Here we report a novel heterozygote point mutation in the LH receptor gene of a Brazilian boy with gonadotropin-independent precocious puberty. This mutation substitutes alanine 568 with valine at the carboxyterminus of the third cytosolic loop of the LH receptor. The unoccupied mutant receptors confer constitutive activation of adenyl cyclase activity when expressed in COS-7 cells, resulting in 4-fold higher cAMP concentrations over baseline compared with cells expressing an equivalent number of wild-type receptors. The affinity of the mutant receptors to 125I-labeled human LH was not altered compared with the wild type. Mutations of the homologue alanine residue in the alpha 1- adrenergic (in vitro), FSH (in vitro), and TSH (naturally occurring) receptors also result in constitutive adenyl cyclase activation, suggesting that this alanine residue is crucial for signal transduction and a potential site for upregulatory/oncogenic mutations in G-protein coupled receptors.
This article has been cited by other articles:
 |
|
 |
|
  M. J. S. Chee, K. Morl, D. Lindner, N. Merten, G. W. Zamponi, P. E. Light, A. G. Beck-Sickinger, and W. F. Colmers The Third Intracellular Loop Stabilizes the Inactive State of the Neuropeptide Y1 Receptor J. Biol. Chem., November 28, 2008; 283(48): 33337 - 33346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ascoli, F. Fanelli, and D. L. Segaloff The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective Endocr. Rev., April 1, 2002; 23(2): 141 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Domenice, A. C. Latronico, V. N. Brito, I. J. P. Arnhold, F. Kok, and B. B. Mendonca Adrenocorticotropin-Dependent Precocious Puberty of Testicular Origin in a Boy with X-Linked Adrenal Hypoplasia Congenita Due to a Novel Mutation in the DAX1 Gene J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4068 - 4071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Lee, T. J. Kotlar, I. Ciric, M. K. Lee, S. K. Lim, H. C. Lee, K. B. Huh, K. E. Mayo, and J. L. Jameson Absence of Constitutively Activating Mutations in the GHRH Receptor in GH-Producing Pituitary Tumors J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3989 - 3995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Latronico, H. Shinozaki, G. Guerra Jr., M. A. A. Pereira, S. H. V. Lemos Marini, M. T. M. Baptista, I. J. P. Arnhold, F. Fanelli, B. B. Mendonca, and D. L. Segaloff Gonadotropin-Independent Precocious Puberty Due to Luteinizing Hormone Receptor Mutations in Brazilian Boys: A Novel Constitutively Activating Mutation in the First Transmembrane Helix J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4799 - 4805. [Abstract] [Full Text]
|
|
|
|
|
|
A. P. N. Themmen and I. T. Huhtaniemi Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function Endocr. Rev., October 1, 2000; 21(5): 551 - 583. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Kudo, T. Chen, K. Nakabayashi, S. Yu Hsu, and A. J. W. Hsueh The Nematode Leucine-Rich Repeat-Containing, G Protein-Coupled Receptor (LGR) Protein Homologous to Vertebrate Gonadotropin and Thyrotropin Receptors is Constitutively Activated in Mammalian Cells Mol. Endocrinol., February 1, 2000; 14(2): 272 - 284. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Y. Adashi and J. D. Hennebold Single-Gene Mutations Resulting in Reproductive Dysfunction in Women N. Engl. J. Med., March 4, 1999; 340(9): 709 - 718. [Full Text] [PDF]
|
|
|
|
|
|
H. Kremer, J. W. M. Martens, M. van Reen, M. Verhoef-Post, J. M. Wit, B. J. Otten, S. L. S. Drop, H. A. Delemarre-van de Waal, M. Pombo-Arias, F. De Luca, et al. A Limited Repertoire of Mutations of the Luteinizing Hormone (LH) Receptor Gene in Familial and Sporadic Patients with Male LH-Independent Precocious Puberty J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1136 - 1140. [Abstract] [Full Text]
|
|
|
|
|
|
A. N. Abell, D. J. McCormick, and D. L. Segaloff Certain Activating Mutations within Helix 6 of the Human Luteinizing Hormone Receptor May Be Explained by Alterations That Allow Transmembrane Regions to Activate Gs Mol. Endocrinol., December 1, 1998; 12(12): 1857 - 1869. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. C. Ganguli, C.-G. Park, M. H. Holtmann, E. M. Hadac, T. P. Kenakin, and L. J. Miller Protean Effects of a Natural Peptide Agonist of the G Protein-Coupled Secretin Receptor Demonstrated by Receptor Mutagenesis J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 593 - 598. [Abstract] [Full Text]
|
|
|
|
|
|
A. C. Latronico, A. N. Abell, I. J. P. Arnhold, X. Liu, T. S. S. Lins, V. N. Brito, A. E. Billerbeck, D. L. Segaloff, and B. B. Mendonca A Unique Constitutively Activating Mutation in Third Transmembrane Helix of Luteinizing Hormone Receptor Causes Sporadic Male Gonadotropin-Independent Precocious Puberty J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2435 - 2440. [Abstract] [Full Text]
|
|
|
|
|
|
A.-M. Andersson, A. Juul, J. H. Petersen, J. Muller, N. P. Groome, and N. E. Skakkebak Serum Inhibin B in Healthy Pubertal and Adolescent Boys: Relation to Age, Stage of Puberty, and Follicle-Stimulating Hormone, Luteinizing Hormone, Testosterone, and Estradiol Levels J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3976 - 3981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yano, L. D. Kohn, M. Saji, A. Okuno, and G. B. Cutler Jr. Phe576 Plays an Important Role in the Secondary Structure and Intracellular Signaling of the Human Luteinizing Hormone/Chorionic Gonadotropin Receptor J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2586 - 2591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Misrahi, G. Meduri, S. Pissard, C. Bouvattier, I. Beau, H. Loosfelt, A. Jolivet, R. Rappaport, E. Milgrom, and P. Bougneres Comparison of Immunocytochemical and Molecular Features with the Phenotype in a Case of Incomplete Male Pseudohermaphroditism Associated with a Mutation of the Luteinizing Hormone Receptor J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2159 - 2165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Abell and D. L. Segaloff Evidence for the Direct Involvement of Transmembrane Region 6 of the Lutropin/Choriogonadotropin Receptor in Activating Gs J. Biol. Chem., June 6, 1997; 272(23): 14586 - 14591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Schipani, G. S. Jensen, J. Pincus, R. A. Nissenson, T. J. Gardella, and H. Jüppner Constitutive Activation of the Cyclic Adenosine 3',5'-Monophosphate Signaling Pathway by Parathyroid Hormone (PTH)/PTH-Related Peptide Receptors Mutated at the Two Loci for Jansen's Metaphyseal Chondrodysplasia Mol. Endocrinol., June 1, 1997; 11(7): 851 - 858. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. Kotlar, R. H. Young, C. Albanese, W. F. Crowley Jr., R. E. Scully, and J. L. Jameson A Mutation in the Follicle-Stimulating Hormone Receptor Occurs Frequently in Human Ovarian Sex Cord Tumors J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1020 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-B. Hu, L. Johnson, P. C. Roche, and H. T. Keutmann A Functional Determinant in Human Luteinizing Hormone and Chorionic Gonadotropin: Differential Effect of Mutations about {beta}-GLN-54 Endocrinology, April 1, 1997; 138(4): 1627 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kosugi, T. Mori, and A. Shenker The Role of Asp578 in Maintaining the Inactive Conformation of the Human Lutropin/Choriogonadotropin Receptor J. Biol. Chem., December 13, 1996; 271(50): 31813 - 31817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Charpentier, K. R. Jarvie, D. M. Severynse, MarcG. Caron, and M. Tiberi Silencing of the Constitutive Activity of the Dopamine D1B Receptor. RECIPROCAL MUTATIONS BETWEEN D1 RECEPTOR SUBTYPES DELINEATE RESIDUES UNDERLYING ACTIVATION PROPERTIES J. Biol. Chem., November 8, 1996; 271(45): 28071 - 28076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kudo, Y. Osuga, B. K. Kobilka, and A. J.W. Hsueh Transmembrane Regions V and VI of the Human Luteinizing Hormone Receptor Are Required for Constitutive Activation by a Mutation in the Third Intracellular Loop J. Biol. Chem., September 13, 1996; 271(37): 22470 - 22478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Latronico, J. Anasti, I. J.P. Arnhold, R. Rapaport, B. B. Mendonca, W. Bloise, M. Castro, C. Tsigos, and G. P. Chrousos Testicular and Ovarian Resistance to Luteinizing Hormone Caused by Inactivating Mutations of the Luteinizing Hormone-Receptor Gene N. Engl. J. Med., February 22, 1996; 334(8): 507 - 512. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
